Following child deaths linked to cough syrups, India's drug regulator has issued an urgent alert to states. Manufacturers are now mandated to rigorously test all raw materials and finished products, ensuring compliance with drug-testing rules. The directive emphasizes robust vendor qualification and sourcing from approved suppliers to prevent future health risks to children.